Literature DB >> 15652255

Individual differences in cardiovascular response to social challenge.

Andrea Sgoifo1, Tania Costoli, Peter Meerlo, Bauke Buwalda, Maria Angeles Pico'-Alfonso, Sietse De Boer, Ezio Musso, Jaap Koolhaas.   

Abstract

An important determinant of cardiovascular stress reactivity and morbidity is the individual behavioral strategy of coping with social challenge. This review summarizes the results of a number of studies that we performed in rats, aimed at investigating the relationship between aggression and cardiovascular responsivity under social stress conditions. We show that rats belonging to the 'aggressive tail' of a population are characterized by a higher sympathetic-adrenomedullary activation during social and non-social stress episodes. Wild-type rats are characterized by a larger sympathetic dominance and a higher susceptibility to cardiac arrhythmias during defeat as compared to Wistars. Cardiovascular habituation takes place when social challenge is an intermittent victory experience, whereas no habituation is observed across repeated defeat episodes. Dominant rats whose social dominance is challenged by the aggression of another subject display long-term alterations of heart rate circadian rhythmicity. Such changes are linked to individual proness to defend social dominance: the more the animal counterattacks the aggressor, the smaller the subsequent rhythm disturbance. These data underline how important it is to carefully consider individual differences in aggression and the context in which aggression is expressed, when studying cardiovascular effects of social interactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15652255     DOI: 10.1016/j.neubiorev.2004.07.001

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  8 in total

1.  Activity of the positive and negative reinforcement motivation systems and baseline arterial blood pressure in humans.

Authors:  L I Aftanas; P V Sidorova; S V Pavlov; V P Makhnev; V V Korenek; N V Reva; T G Amstislavskaya
Journal:  Neurosci Behav Physiol       Date:  2008-09-18

2.  Independent effects of early-life experience and trait aggression on cardiovascular function.

Authors:  Samir Rana; Phyllis C Pugh; Erin Katz; Sara A Stringfellow; Chee Paul Lin; J Michael Wyss; Harald M Stauss; C Roger White; Sarah M Clinton; Ilan A Kerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-08       Impact factor: 3.619

3.  Distinct effects of early-life experience and trait aggression on cardiovascular reactivity and recovery.

Authors:  Samir Rana; Phyllis C Pugh; J Michael Wyss; Sarah M Clinton; Ilan A Kerman
Journal:  Physiol Behav       Date:  2018-12-04

Review 4.  Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake.

Authors:  Klaus A Miczek; Jasmine J Yap; Herbert E Covington
Journal:  Pharmacol Ther       Date:  2008-08-15       Impact factor: 12.310

5.  Reduced serotonergic functioning changes heart rate in ADHD.

Authors:  Florian Daniel Zepf; M Holtmann; C Stadler; L Wöckel; F Poustka
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

Review 6.  Heart rate as a measure of emotional arousal in evolutionary biology.

Authors:  Claudia A F Wascher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-06-28       Impact factor: 6.671

7.  The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2.

Authors:  Brandon H Cline; Harry W M Steinbusch; Dmitry Malin; Alexander V Revishchin; Galia V Pavlova; Raymond Cespuglio; Tatyana Strekalova
Journal:  BMC Neurosci       Date:  2012-09-18       Impact factor: 3.288

8.  Vagal withdrawal and susceptibility to cardiac arrhythmias in rats with high trait aggressiveness.

Authors:  Luca Carnevali; Mimosa Trombini; Alberto Porta; Nicola Montano; Sietse F de Boer; Andrea Sgoifo
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.